Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Thermo Fisher Scientific, Swift Biosciences, More

Thermo Fisher Scientific Ion AmpliSeq SARS-CoV-2 Research Panel

Thermo Fisher Scientific has launched the Ion AmpliSeq SARS-CoV-2 Research Panel. It consists of two pools with amplicons 125 to 275 base pairs in length that cover more than 99 percent of the viral genome, and requires as little as 1 ng of total RNA input. The panel runs on the Ion GeneStudio S5 sequencer and was recently optimized to also run on the Ion Torrent Genexus system.


Swift Biosciences SARS-CoV-2 Research Panel

Swift Biosciences has released a research-use targeted sequencing panel for SARS-CoV-2. The amplicon-based multiplex panel targets the full 30 kb viral genome in a single tube, two-hour workflow with two rounds of PCR. More than three hundred primer pairs help increase sensitivity and specificity due to the higher probability of amplifying limited quantities of viral template material, as does the ability to use sequencing to confirm that reads are mappable to SARS-CoV-2 instead of similar coronaviruses or pathogens, the company said. Swift's workflow also adds sequencing adapters directly without the need for a secondary library construction.


Saama, Indx.AI COVID-19 Command Center

Clinical analytics firm Saama Technologies and multiomics data integrator Indx.AI have launched COVID-19 Command Center, a cloud-based platform to help life sciences companies accelerate R&D on potential therapies and vaccines for COVID-19. The product is meant to allow trial sponsors working on in-house clinical development to manage studies with the same technology offered by the recently established EndPandemic National Data Consortium, which Saama launched and of which Indx.AI is a founding member.


For more new products and services, please visit the New Products page on our website.